Can Bitovil/Bikonprenol tablets be used as PrEP? Effectiveness and safety of HIV prevention

Biktarvy is a fixed-dose combination drug widely used to treat human immunodeficiency virus (HIV) infection. It contains three anti-HIV drugs: bictegravir, emtricitabine and tenofovir alafenamide (TAF). Its main function is to help infected people control virus replication and achieve the effect of suppressing HIV.

As for whether BITOVIL can be used as a pre-exposure prophylaxis (PrEP) drug, the answer is that there is currently insufficient clinical evidence that BITOVIL can be used as a PrEP drug. PrEP drugs are preventive measures for high-risk groups. Common drugs include tenofovir fumarate combined with emtricitabine. These drugs have been proven to be effective in reducing the risk of HIV infection. PrEP medication is taken regularly every day to provide protection against exposure to the HIV virus.

Although the tenofovir fumarate contained in Bituvi is the same as PrEP, it is mainly used for patients already infected with HIV to control the virus rather than prevent HIV infection. Therefore, Bituvail is not officially recommended as part of PrEP treatment. Researchers are conducting relevant studies to explore whether it can play a role in preventing HIV, but current official guidance still relies on existing PrEP drugs.

Patients should strictly follow the doctor's advice when using Bitovil and should not use it as PrEP on their ownPrEP. For those at high risk, doctors recommend the proven drug PrEP and recommend regular testing for HIV status and other possible complications.

In general, although Bituvi has anti-HIV effects, it is not a drug designed to prevent HIV infection. Therefore, if you want to use PrEP drugs to prevent HIV, you should choose drugs that are clinically proven and approved by regulatory agencies.

Reference materials:https://www.biktarvy.com/